Biphenotypic/Undifferentiated/Prolymphocytic Leukemias
Showing 1 - 25 of 295
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 4, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)
Recruiting
- Hematologic Malignancies
- Haplo HCT <55 years old
- +4 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 25, 2023
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)
Terminated
- Acute Lymphoblastic Leukemia
- +17 more
- Infusion of Treg
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Sep 8, 2020
Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)
Active, not recruiting
- Sarcoma, Soft Tissue
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 29, 2023
Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)
Completed
- Leukemia
- +2 more
-
Boston, Massachusetts
- +14 more
Nov 23, 2022
CLL, SLL, HCL Trial in Dresden
Recruiting
- CLL
- +7 more
-
Dresden, Sachsen, GermanyBAG Freiberg-Richter, Jacobasch, Wolf, Illmer
Apr 29, 2022
Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)
Active, not recruiting
- Thyroid Cancer
- +2 more
-
Stanford, CaliforniaStanford University
Nov 8, 2022
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded
Not yet recruiting
- Refractory Leukemia
- +4 more
- STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- Dendritic Cell Vaccine
-
Miami, FloridaUniversity of Miami
Jan 23, 2023
Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)
Not yet recruiting
- Undifferentiated Pleomorphic Sarcoma
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Nov 1, 2023
Transient Loss of Consciousness and Suspected Syncope in
Recruiting
- Syncope
- Data collection
-
Durres, Albania
- +56 more
Oct 4, 2022
Agitation, Schizophrenia, Schizoaffective Disorder Trial (Sublingual film containing dexmedetomidine (BXCL501))
Not yet recruiting
- Agitation
- +4 more
- Sublingual film containing dexmedetomidine (BXCL501)
- (no location specified)
Jul 26, 2023
Sinonasal Undifferentiated Carcinoma Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Sinonasal Undifferentiated Carcinoma
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
Jun 21, 2023
Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati
Recruiting
- Relapsed/Refractory Leukemias
- +4 more
- SNDX-5613
- +2 more
-
Kansas City, Missouri
- +1 more
Jul 18, 2022
Study and Monitoring of Early Undifferentiated Arthritis
Active, not recruiting
- Early Rheumatoid Arthritis or Early Undiffentiated Arthritis
- (no location specified)
Oct 25, 2022
Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis
Active, not recruiting
- Rheumatoid Arthritis
- MRI
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound
Recruiting
- Undifferentiated Pleomorphic Sarcoma
- ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Development of B-cell Leukemias and Lymphomas in Children of
Not yet recruiting
- B Cell Leukemia
- Lymphoma
- SNP analysis of the DNA
- (no location specified)
Oct 26, 2021
Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate
Recruiting
- Non Malignant Diseases
- +2 more
- RIC: Distal Campath
- +2 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 8, 2022
The Pediatric Acute Leukemia Screening Trial - A Study to Test
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +7 more
- Biospecimen Collection
-
Birmingham, Alabama
- +144 more
Jan 30, 2023
Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in
Active, not recruiting
- Dedifferentiated Liposarcoma
- +5 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022